Support Alert

Drug Safety Update: Oral retinoid medicines - revised and simplified pregnancy prevention educational materials for healthcare professionals and women

The Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update highlights new and updated advice:

  • New prescriber checklists
  • Patient reminder cards
  • Pharmacy checklists are available to support the Pregnancy Prevention Programme in women taking acitretin, alitretinoin, and isotretinoin
  • Advice about the risk of neuropsychiatric reactions has been made consistent for all oral retinoid medicines.

Further details of the Drug Safety Update and advice for healthcare professionals can be found on the MHRA website.


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.